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Abstract
Purpose: Combining specific and quantitative F-19 magnetic resonance imaging (MRI) with
sensitive and convenient optical imaging provides complementary information about the
distribution and viability of transplanted pancreatic islet grafts. In this study, pancreatic islets
(PIs) were labeled with positively charged multimodal nanoparticles based on poly(lactic-co-
glycolic acid) (PLGA-NPs) with encapsulated perfluoro-15-crown-5-ether and the near-infrared
fluorescent dye indocyanine green.
Procedures: One thousand and three thousand bioluminescent PIs were transplanted into subcuta-
neous artificial scaffolds, which served as an alternative transplant site. The grafts were monitored using
in vivo F-19 MR, fluorescence, and bioluminescence imaging in healthy rats for 2 weeks.
Results: Transplanted PIs were unambiguously localized in the scaffolds by F-19 MRI
throughout the whole experiment. Fluorescence was detected in the first 4 days after
transplantation only. Importantly, in vivo bioluminescence correlated with the F-19 MRI signal.
Conclusions: We developed a trimodal imaging platform for in vivo examination of transplanted
PIs. Fluorescence imaging revealed instability of the fluorescent dye and its limited applicability
for longitudinal in vivo studies. A correlation between the bioluminescence signal and the F-19
MRI signal indicated the fast clearance of PLGA-NPs from the transplantation site after cell
death, which addresses a major issue with intracellular imaging labels. Therefore, the proposed
PLGA-NP platform is reliable for reflecting the status of transplanted PIs in vivo.
Key words: F-19 magnetic resonance imaging, Optical imaging, Pancreatic islets, Transplan-
tation, Nanoparticles
Introduction
Intrahepatic transplantation of pancreatic islets (PIs) repre-
sents an alternative treatment for patients with unstable type
1 diabetes mellitus. Although insulin independence can be
achieved in these patients, persistence of normoglycemia is
limited, while grafts are partially or fully rejected after a
certain time even with multiple repetitions of the transplan-
tation procedure [1]. Moreover, transplantation into the liver
is often accompanied by several complications that may
contribute to graft impairment. Therefore, various extrahe-
patic transplantation sites have been tested [2]; of these sites,
artificial macroporous scaffolds have shown promising
transplantation efficiency [3–6].
Non-invasive in vivo monitoring of transplanted islets can
reveal the processes underlying islet engraftment and
rejection through the assessment of islet viability, distribu-
tion, and mass. Precise monitoring by a reliable method may
ultimately contribute to the improvement of transplantation
outcomes. Visualization of transplanted islets requires
labeling by a suitable contrast agent or genetic modification
of isolated islets in order to obtain a specific signal from the
transplanted islets in the host tissue. Various imaging
modalities have been implemented for tracking transplanted
islets, such as radionuclide methods [7, 8], magnetic
resonance imaging (MRI) [9], optical imaging [10, 11],
and ultrasound [12]. Each method provides different
information and is affected by various limitations, such as
low spatial resolution (radionuclide imaging), low specificity
(proton (H-1) MRI), low sensitivity (fluorine (F-19) MRI),
and signal attenuation (optical methods). Therefore, com-
bining multiple imaging methods is desirable as it can
provide more precise, complementary, and complete
information.
The most widely used and clinically implemented MRI
agents for islet labeling are superparamagnetic iron oxide
nanoparticles (SPIONs) [13, 14] that are suitable for
visualization by H-1 MRI. However, highly sensitive
SPIONs possess low imaging specificity due to the presence
of other in vivo sources of hypointense signals and thus are
difficult to quantify. Fluorine-containing probes provide
high specificity for in vivo detection by F-19 MRI due to
the negligible amount of MR-detectable fluorine in biolog-
ical tissues. Compared to other methods, the advantages of
F-19 MRI are its high specificity, a similar resonance
frequency to H-1, and the option for absolute quantification
[15]. MRI requires a concentration in the order of millimolar
for reliable detection. To achieve it in a cell implant, either
high cellular uptake of the probe or probes containing more
F-19 nuclei per molecule (e.g., perfluorocarbons (PFC)) are
required. Perfluoro-15-crown-5-ether (PFCE) with 20 equiv-
alent fluorine nuclei is currently one of the mostly used PFC
imaging agents [16]. PFCs are both hydrophobic and
lipophobic synthetic compounds. Due to these properties,
liquid PFCs are usually delivered as surfactant-stabilized
PFC emulsions or, less often, entrapped in poly(lactic-co-
glycolic acid) (PLGA) nanoparticles for F-19 MRI [17]. The
encapsulation of PFC in PLGA nanoparticles leads to the
further incorporation of various compounds, such as dyes,
on the surface or inside of the nanoparticles, thus enabling
multimodal imaging [18].
Recently, several studies reported on the application of F-19
probes for in vivo tracking of labeled cells [19–23], and also
pancreatic islets [24, 25]. In the study by Barnett et al., human
PIs were labeled with multimodal perfluorooctylbromide (for
F-19 MRI, computed tomography and ultrasound) and
transplanted under the kidney capsules of mice and rabbits.
Although the transplanted islets were visualized in vivo, 2000
and 10,000 islets were needed to reach a sufficient signal-to-
noise ratio (SNR) level at 9.4 T and 3 T respectively. Recently,
200 murine islets were transplanted and visualized at mouse
thigh [25]. In this study and also in other cases of intracellular
labeling, signal persistence in the tissue due to slow clearance
of the label after cell death is a major issue [26, 27].
Although optical imaging involving fluorescence and
bioluminescence (BLI) is a very sensitive method in
contrast to F-19 MRI, it suffers from light scattering and
absorption in biological tissues. Therefore, near-infrared
(NIR) fluorescent dyes with lower attenuation are favor-
able for in vivo applications. The main advantage of BLI
is the option to monitor islet viability in vivo [28].
However, it can be only implemented in experimental
studies due to necessary genetic alteration of islets for
luciferase expression.
In our previous study, we focused on optimizing a
protocol for PI labeling using PLGA-based nanoparticles
(PLGA-NPs) containing both PFCE and the NIR probe
indocyanine green (ICG). PIs were visualized in vitro using
F-19 MRI and fluorescence imaging [29]. The aim of the
current study was to monitor the fate of PIs labeled with
bimodal PLGA-NPs after transplantation into artificial
scaffolds using trimodal imaging (F-19 MRI, fluorescence,
and bioluminescence imaging). Importantly, the biolumines-
cence reporter constructor is a direct marker for PI viability
and was used to validate the F-19 data in vivo. Together, the
BLI and F-19 MRI data could address the main issue about
clearance of probes from dead islets/cells and their contri-
bution to false positives in the MRI data.
Materials and Methods
All animal protocols were approved by the Ethics Commit-
tee of the Institute for Clinical and Experimental Medicine
and the Ministry of Health of the Czech Republic (No. 58/
2014) in accordance with the European Communities
Council Directive (2010/63/EU).
Isolation of Pancreatic Islets
Pancreatic islets were isolated from transgenic Lewis rats
either with ubiquital expression of a gene for the luciferase
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enzyme (National BioResource Project – Rat, Kyoto, Japan)
or from their non-bioluminescent littermates. Ten luciferase-
negative (LUC−) animals were used as donors for in vitro
examination of islets, while 20 luciferase-positive (LUC+)
animals were used as donors of pancreatic islets for
transplantation.
Isolation of pancreatic islets was performed according to
a standard protocol described by Gotoh [30]. A culture
medium containing 84 % CMRL-1066 medium, 10 % FBS,
5 % HEPES, 0.5 % penicillin/streptomycin (all Sigma-
Aldrich, USA), and 0.5 % glutaMAX (Thermo Fisher
Scientific, USA) was used throughout the study. After
isolation, pancreatic islets were incubated (37 °C, CO2
atmosphere) in the culture medium overnight for recovery.
Labeling of Pancreatic Islets
Viability and Functionality Assessment of Labeled
Islets
Viability of labeled islets was assessed by staining with
fluorescent dyes to reflect cell membrane integrity. Ten islets
(in 20 μl of Hanks solution) were handpicked and placed in
a well containing 9.4 μM of propidium iodide and 75 μM of
acridine orange. After 5 min, 200 μl of PBS was added and
the suspension was examined under a fluorescent micro-
scope. Viability was expressed as the number of live (green)
and dead (orange) cells. The ratio of live cells to all cells in
the ten chosen islets was expressed as a percentage. Viability
of labeled and unlabeled islets was also assessed by in vitro
bioluminescence imaging.
The functional status of the labeled islets was tested using
a glucose-stimulated insulin secretion test. Duplicates of 50
labeled and unlabeled islets were subsequently incubated
(37 °C, 5 % CO2 atmosphere) in a basal Krebs medium
containing low (3.3 mM), then high (22 mM) and low
(3.3 mM) glucose concentrations again. After each incuba-
tion, an aliquot of the medium was taken and frozen at −
20 °C. Insulin content was then measured using an ELISA
test. The amount of insulin released from the islets upon
glucose stimulation was assessed as the glucose stimulation
index representing the ratio of insulin content according to
high and low glucose samples.
Imaging Sensitivity Assessment of Labeled Islets
All optical images (bioluminescence and fluorescence) were
acquired on an IVIS Lumina XR imager (Perkin Elmer,
USA) and processed using Living Image software (Perkin
Elmer, USA). MRI imaging was performed on a 4.7 T
scanner (Bruker BioSpin, Germany) using a home-made
dual H-1/F-19 surface single-loop circular radiofrequency
(RF) coil with a diameter 4 cm.
To assess the minimum number of labeled islets
detectable by bioluminescence, different numbers (10, 30,
50, 100, 300) of bioluminescent islets labeled with multi-
modal nanoparticles (endocytosis 17 mg/ml of PLGA-NP) as
well as unlabeled islets were placed in wells containing the
medium. The bioluminescent images were measured within
a 1-min exposure time after the addition of D-Luciferin
(0.15 mg/ml; Medesa, Czech Republic).
Estimation of F-19 MRI and fluorescence imaging
sensitivity was performed using fixed labeled islets (endo-
cytosis 12 mg/ml, 17 mg/ml, and 23 mg/ml of PLGA-NPs)
placed in test tubes in different quantities (50, 100, and 300
islets).
In vitro MRI measurement: T2-weighted H-1 MRI images
were acquired for reference using a turbo spin echo sequence
with the following parameters: repetition time TR = 3000 ms,
echo spacing TE = 12 ms, effective echo time TEeff = 36 ms,
turbo factor 8, spatial resolution of 0.19 × 0.19 × 2 mm3,
number of acquisitions NA = 4, and scan time 1 min. Coronal
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The bimodal PLGA-based nanoparticles were prepared
using a single-emulsion solvent evaporation method as
described previously [18]. Briefly, 100 mg of PLGA was
dissolved in 3 ml dichloromethane. Nine hundred microliters
of PFCE and 1 mg of indocyanine green was added to the
organic phase. Next, the organic phase was added to the
aqueous phase containing a surfactant under ultrasonication.
To formulate positively charged particles, the protocol was
slightly modified by adding 0.4 g of diethylaminoethyl-
dextran (Sigma-Aldrich, Germany) to the aqueous phase.
The size of the nanoparticles—measured using dynamic
light scattering (DLS; Zetasizer Nano – Malvern Instruments
Ltd., UK)—was 180 nm with a polydispersity index of 0.1.
The PFCE content—measured on a Bruker Avance III
400 MHz NMR spectrometer (Bruker, Germany)—was
1.8 × 1018 fluorine atoms per milligram of the lyophilized
sample. The bimodal nanoparticles (in the form of a freeze-
dried powder) were resuspended in phosphate-buffered
saline (PBS) before brief bath sonication.
For the in vitro experiment, the isolated PIs were
labeled by endocytosis. The islets were incubated for
24 h (37 °C, 5 % CO2) in a culture medium containing
12 mg/ml, 17 mg/ml, and 23 mg/ml of the PLGA-NPs (500
islets for each concentration). They were then collected
and washed three times with Hanks solution (Sigma-
Aldrich, USA) after labeling. Control islets were incubated
in a medium without nanoparticles and treated in the same
way as the labeled islets. These islets were counted in a
black well, handpicked, and subsequently fixed with 4 %
formaldehyde.
For transplantation, the isolated islets were incubated for
24 h in the culture medium containing 17 mg/ml of PLGA-
NPs, a quantity chosen based on the in vitro results. Control
islets were incubated in a medium without nanoparticles.
These islets were then washed three times with Hanks
solution supplemented with 1 % fetal bovine serum (FBS),
counted under a microscope, and placed in a plastic tube
prior to transplantation.
F-19 MRI images were acquired using a turbo spin echo
sequence with the following parameters: TR = 1000 ms,
TE = 3.2 ms, TEeff = 42.2 ms, turbo factor 32, spatial
resolution 1.56 × 1.56 × 15 mm3, NA = 4096, and scan time
1 h 8 min. F-19 MRI images were interpolated from matrix
32 × 32 to 256 × 256, converted to false colors, and then co-
registered with H-1 MRI images using ImageJ software
(version 1.46r, National Institutes of Health, USA) [31].
SNR values were calculated from the manually outlined
regions of interest (ROIs) placed on each sample, a reference
and a noise region in the F-19 MRI images using ImageJ.
The fluorine content of the labeled islets (FPI) was
calculated from the F-19 MRI images by comparing the
signal of labeled islets SPI to the signal of reference SREF1
(containing a known number of F-19 atoms FREF1 in the
voxel). The agent uptake was calculated according to the
formula:
FPI ¼ SPISREF1*N*FREF1; ð1Þ
where N represents the number of PIs in the sample and
expressed as the number of F-19 atoms incorporated in one
islet/endocrine cell (assuming that 1 islet contains approxi-
mately 1000 cells).
Fluorescence images of the same samples were acquired
during a 2-s exposure using aperture (f/stop) 4 and binning
4. Fluorescence excitation was set at 745 nm and emission at
810–875 nm. ROIs of the same size were drawn around each
tube and the emitted optical signal was expressed as the
radiance efficiency ([photons/s/cm2/sr]/(μW/cm2)). Fluores-
cence images were overlaid on photographs for reference.
Animal Model of Extrahepatic Pancreatic Islet
Transplantation
Male Lewis rats (Velaz, Czech Republic) weighing 350–
450 g (n = 3) were chosen as the recipients of the pancreatic
islets. A surgical non-fluorescent mesh was shaped into
rounded scaffolds, which served as an artificial transplanta-
tion site. During surgery, the animals were kept under
inhalation anesthesia using isoflurane (5 % for induction,
2 % during the surgery). Two incisions were made in the
abdominal area of the rats before subcutaneously implanting
scaffolds into the cavities created using scissors (two
scaffolds per one animal). The implanted scaffolds were
supplemented with polytetrafluoroethylene rods completely
filling the cavity to avoid obliteration of the internal scaffold
space. The rods were removed and the cavities closed using
small polytetrafluoroethylene plugs 1 week after scaffold
implantation. Three days after, the pancreatic islets were
transplanted into the exposed cavities using a Hamilton
syringe supplemented with a thin plastic tube in order to
ensure the slow controlled injection of a large volume of
islets (avoiding syringe obstruction). The scaffolds were
closed using the plugs after transplantation and the incisions
were tightly closed using 5–0 Vicryl sutures (Ethicon,
Johnson & Johnson Medical, Ltd., UK).
The animals received the labeled LUC+ islets (3000 and
1000 in each scaffold) or the unlabeled LUC+ islets (3000
and 1000) as controls.
In Vivo Trimodal Imaging of Pancreatic Islets
Transplanted into Artificial Scaffolds
Animals with transplanted islets were examined by biolumi-
nescence, fluorescence, and F-19 MRI imaging on days 1, 4,
8, and 14 after islet transplantation using the same MRI
scanner, RF coil, and optical imager for the in vitro study.
The rats were shaved in the area of the scaffolds prior to
imaging in order to eliminate scattering and attenuation of
the optical signal. The rats were anesthetized by intramus-
cular anesthesia (ketamine 36 mg/kg and dexmedetomidine
0.08 mg/kg).
In vivo fluorescence imaging was performed based on
the same parameters used for the phantom study with an
exposure time of 60 s. Bioluminescence images were then
acquired before and after intravenous administration of D-
luciferin solution (70 mg/kg) with a 60-s exposure time
and an open emission filter. Bioluminescent images were
overlaid on photographs for co-registration of the biolumi-
nescent signal. ROIs of the same size were carefully
outlined around each scaffold before calculating the total
radiance efficiency ([photons/s/cm2/sr]/(μW/cm2) for fluo-
rescence and the total radiance (photons/s/cm2/sr) for
bioluminescence.
MRI was performed after optical imaging. Axial and
coronal T2-weighted H-1 MRI images were acquired using
the same parameters used for the phantom study (except
for a spatial resolution of 0.23 × 0.23 × 2 mm3 and a scan
time of 2.5 min). The frequency was then adjusted to the
F-19 signal of a reference (containing a suspension of the
nanoparticles in water at concentration 30 × 1018 F-19
atoms/ml) placed in close proximity to the scaffolds. Axial
F-19 MRI images were acquired using a turbo spin echo
sequence with the following parameters: TR = 1500 ms,
TE = 3.2 ms, TEeff = 42.2 ms, turbo factor 32, slice
thickness 20 mm, FOV = 60 × 33 mm, spatial resolution
1.9 × 1.0 × 20 mm3, NA = 768 (scan time 19 min), or NA =
2048 (scan time 51 min). The slice was oriented perpen-
dicular to the main axis of the scaffold, with the selected
slice thickness, thus covering the signal from the whole
scaffold. F-19 MRI images were interpolated from the
acquired matrix 32 × 32 to 256 × 256, converted to false
colors, and then co-registered with anatomical H-1 MRI
images using ImageJ.
The number of engrafted islets NTxPI was quantified from
the F-19 MRI images by comparing the signal of the
transplanted islets STxPI to the signal of reference SREF2 and
by taking into account the amount of F-19 atoms in
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reference FREF2 and the agent uptake per one islet FPI
estimated in the in vitro study. The number of islets was then
calculated as
NTxPI ¼
STxPI
SREF2
*FREF2
FPI
: ð2Þ
Histological Analysis
Two weeks after islet transplantation, the scaffolds were
removed, fixed in 10 % neutral-buffered formalin, and
embedded in paraffin blocks. Four-micrometer-thick paraffin
sections were cut and routinely stained with hematoxylin
and eosin (HE) and Verhoeff-Van Gieson elastin stain.
Immunohistochemical detection of insulin (mouse monoclo-
nal, MU029-UC, Biogenex, USA) and luciferase (mouse
monoclonal, Luci 21 1-107, Novus Biologicals, USA) was
performed on 4-μm-thick paraffin sections. The primary
anti-insulin antibody was detected using Simple Stain MAX
PO (MULTI) Universal Immuno-peroxidase Polymer anti-
mouse, anti-rabbit Histofine (Nichirei Biosciences, Japan).
Histofine Simple Stain Rat MAX PO (Nichirei, Japan) was
used for detecting luciferase. Finally, visualization was
performed using the Dako Liquid DAB+ Substrate-
Chromogen System (Agilent, USA) and counterstaining
with Harris’s hematoxylin. The slides were viewed using
standard light microscopy (Olympus BX41).
Statistical Analysis
Statistical analysis was conducted using GraphPad Prism
6.02 (GraphPad Software Inc., USA). Values in the graphs
are reported as mean ± standard deviation. Coefficients of
regression (R2) are presented based on the results of linear
regression analysis.
Results
In Vitro Viability and Functionality of Labeled
Islets
Nanoparticle labeling did not affect islet viability, while
labeled islets showed comparable viability to unlabeled islets
(Fig. 1a). Viability of the labeled islets was also confirmed
by in vitro bioluminescence imaging, while labeled islets
provided a similar bioluminescence signal (300
PIs—6.2 × 105 p/s/cm2/sr) to unlabeled controls (300
PIs—6.0 × 105 p/s/cm2/sr) (Fig. 1c, e).
Islet functionality after labeling was confirmed by
measuring the insulin release upon glucose stimulation.
Labeled islets had glucose stimulation indices above 2
(Fig. 1b).
In Vitro Labeling and Visualization of Pancreatic
Islets
Fluorescence imaging confirmed that unlabeled islets emitted
no fluorescence signal after excitation at 745 nm (Fig. 1d, f).
There was a linear relationship between the number of islets
and their in vitro fluorescence and bioluminescence signals
(both R2 = 0.99) (Fig. 1c, d).
In Vivo Imaging of Transplanted Islets Using an
Animal Model
In vivo BLI confirmed the presence of viable transplanted islets
in the scaffolds throughout the entire 14-day experiment
(Fig. 3a). Nanoparticle labeling did not impair the viability or
survival of transplanted islets measured by in vivo biolumines-
cence, as the labeled islets provided a similar bioluminescence
signal compared to unlabeled controls. Both labeled and
unlabeled islets showed maximum bioluminescence on day 4
after transplantation, with the signal decreasing slightly by day
14 (55 % of that on day 4).
The fluorescence signal originating from the labeled islets
reached its maximum immediately after transplantation (day
1), before rapidly decreasing over the next week in all
experimental groups (Fig. 3b). The fluorescence signal
measured on day 1 and day 4 decreased by 73 %, while
unlabeled islets emitted no fluorescence signal at any point.
The localization of labeled islets inside the scaffolds was
also confirmed by F-19 MRI imaging throughout the whole
long-term examination (Fig. 4a). The absolute signal
revealed engraftment of an average of 2300 ± 200 and
1100 ± 300 islets in the scaffolds on day 1, corresponding
to 3000 and 1000 transplanted islets respectively (manually
counted prior to transplantation). The maximum F-19 MRI
signal was detected on the first day after islet transplantation;
after which, the signal continuously declined. However, the
F-19 MRI signal originating from 1000 islets on day 14 was
still above the noise level (Fig. 4b). The signal based on
3000 islets decreased to 66 % of the starting value on day 8
and to 47 % on day 14.
The slow decline of the BLI and F-19 MRI signals
contrasted with the rapid decrease of FLI (Fig. 5). The F-19
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As little as 50 islets were detected by F-19 MRI at an
imaging time of 68 min. The highest F-19 MRI and
fluorescence signals originated from islets labeled by simple
co-incubation with 17 mg/ml of PLGA-NPs for 24 h
(Fig. 2a, b). Fluorescence imaging of labeled islets provided
a higher signal-to-noise ratio within substantially shorter
scanning time than F-19 MRI. We therefore conclude, as
expected, that fluorescence imaging is a more sensitive
detection method (Fig. 2c).
In vitro F-19 MRI revealed incorporation of an average of
5.5 ± 1.8 × 1014 of F-19 per islet (approximately 5.5 ± 1.8 ×
1011 of F-19 atoms per cell) when labeled with 17 mg/ml of
PLGA-NPs (Fig. 2d).
MRI signal strongly correlated with bioluminescence be-
tween days 4 and 14 (R2 = 0.99).
Histology
Two weeks after islet transplantation, the rats were sacrificed
and scaffolds subjected to histological examination. Viable
vascularized pancreatic islets distorted by fibrosis were
present in the central parts of the scaffolds. Irregularly
distributed clusters of cells co-expressing insulin and
luciferase were detected immunohistochemically in all islets
(Fig. 6). Cells expressing both markers were arranged in
trabeculae and occasional small ductular structures. Deposits
of hemosiderin and the foreign body granulomatous reaction
composed of macrophages and multinucleated foreign body
giant cells were detected in some islets.
Discussion
In this study, we used multimodal imaging to track
pancreatic islets transplanted into subcutaneously implanted
artificial scaffolds. This site possesses some benefits over the
liver [3] as less invasive surgery, the possibility of removal
of the whole graft in the case of complications (e.g.,
rejection, inflammation), direct application of drugs, and
the possibility of local enhancement of vascularization (e.g.,
using the vascular factors/stem cells). Moreover, the scaf-
folds are suitable for examining transplanted cells using
various imaging methods [4, 32]. In addition to the grafted
islets being concentrated in one place, which is advanta-
geous for in vivo imaging detection, the scaffolds are
implanted subcutaneously, ensuring a short optical path for
the fluorescence/bioluminescence signal emitted from the
transplanted islets.
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Fig. 1 In vitro characterization of pancreatic islets. a Viability and b glucose stimulation indices of islets after labeling by
endocytosis. Quantification of c in vitro bioluminescence and d fluorescence signals from labeled and unlabeled islets.
Representative e bioluminescence and f fluorescence images of different numbers of labeled (upper row) and unlabeled
(bottom row) islets.
Labeling by endocytosis maintained the viability and
functionality of the labeled islets, which was also proved by
a comparable bioluminescence signal between labeled and
unlabeled islets. Sufficient labeling of islets via endocytosis
using PLGA-NPs was also confirmed by confocal micros-
copy in our previous paper [29]. Since the bioluminescence
signal is dependent on the presence of oxygen and adenosine
triphosphate, only viable cells emit photons in a biolumi-
nescence reaction [28]. Published studies on the following
topics attest to the high viability and insulin secretion of
labeled islets: non-toxicity of probes based on
perfluorocarbons [33] and the safety of selected labeling
methods [29]. The same nanoparticles have been used to
label various subsets of primary human dendritic cells in
preparation for clinical application [34]. Thus, the clinical
application of this procedure is feasible.
In vitro F-19 MRI and fluorescence imaging confirmed
the efficiency of our labeling procedures. Using
Fig. 2 In vitro visualization of pancreatic islets labeled using endocytosis by F-19 MR and fluorescence imaging. a Comparison
of signals originating from 300 islets labeled with different concentrations of nanoparticles. b Representative F-19 MR and FLI
images of different numbers of islets labeled using 17 mg/ml of PLGA-NP. c Visualization sensitivity of various numbers of islets
labeled at a 17 mg/ml concentration, where the relative signal is normalized to the signal from unlabeled islets. d Absolute
quantification of the number of F-19 atoms incorporated in labeled islets.
Fig. 3 Quantification of optical signals from transplanted islets. The time course of a bioluminescence (BLI) and b fluorescence
(FLI) signals originating from labeled and unlabeled islets.
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endocytosis, the highest FLI and MRI signals were detected
from islets labeled with 17 mg/ml of PLGA-NPs, whereas
incubation at a concentration of 23 mg/ml produced a worse
outcome. We speculate that the positively charged fluorine
nanoparticles could aggregate on the islet surface after long
incubation times if the high concentration of PLGA-NPs (≈
23 mg/ml) was used. This excess of nanoparticles could
limit further agent uptake. Nevertheless, labeling using
17 mg/ml of PLGA-NPs led to the incorporation of 5.5 ±
1.8 × 1014 of F-19 per islet (approximately 5.5 ± 1.8 × 1011
of F-19 nuclei), a finding that accords with published data
(range of 1011–1013) [35–37]. The nanoparticles have been
previously shown to locate intracellularly in different cell
types [16, 17].
Fig. 4 F-19 MRI of transplanted islets. a Representative F-19 MR images of pancreatic islets labeled with PLGA-NPs in
artificial scaffolds. b Quantification of the F-19 MR signal from labeled islets.
Fig. 5 Trimodal imaging of transplanted pancreatic islets in scaffolds. a Representative bioluminescence, fluorescence, and
axial F-19/H-1 MR images of 3000 and 1000 pancreatic islets transplanted into scaffolds on days 4 and 14. b Time course of
bioluminescence (BLI), fluorescence (FLI), and F-19 MRI signals for 3000 labeled transplanted islets. MRI signal is recalculated
to the corresponding number of F-19 nuclei (left axis); the optical signals (BLI, FLI) are normalized to the maximum value (=
100 %, right axis).
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In vitro bioluminescence and fluorescence signals
originating from labeled islets correlated with the number
of islets, which points to their reliability for quantifica-
tion of transplanted mass (under in vitro conditions or
immediately after transplantation). Although, 50 islets
were detected by in vitro imaging, a much higher
amount is needed for adequate visualization under
in vivo conditions due to the dispersion of islets in the
scaffolds and scattering and absorption of the optical
signal by the tissue.
Transplanted islets were visualized in artificial scaffolds
by bioluminescence, fluorescence, and F-19 MRI imaging
over 2 weeks. Bioluminescence confirmed the viability of
islets in the scaffolds throughout the whole examination
period with only a partial decrease in islet mass. Absolute
quantification from F-19 MRI images confirmed appropriate
numbers of transplanted islets in scaffolds on day 1 after
islet transplantation. Both 1000 and 3000 islets were
detectable by F-19 MRI for the whole examination (14 days).
The decrease of the F-19 MRI signal to 44 % on day 14
corresponds with published experimental and clinical data
reporting a gradual loss of transplanted islets over 2 weeks
after transplantation [14, 38]. Previous studies have visual-
ized islets labeled by fluorine-containing probes at one time
point post-transplantation only [24, 39] or for several weeks
[25]. The recent study reported a long-term monitoring of
transplanted islets using F-19 MRI, fluorescence, and
bioluminescence imaging within 70 days. While the F-19
MRI and FLI signals were decreasing slowly, the BLI signal
gradually decreased until day 7 (approximately by 80 %),
which means that either dead cells with labels or free
released labels stayed at the site of transplantation. Similar
effect was observed also in other studies with fluorine-
labeled cells resulting to false-positives [16, 21, 27]. In our
model, viability of islets decreased only by 33 % within
14 days after transplantation, which suggest that our
transplantation and imaging model better reflects the status
of transplanted islets. Therefore, our transplantation model
together with the possibility of its monitoring by F-19 MRI
has a greater potential for application in clinical practice.
Moreover, sufficient vascularization is crucial for islet
survival and it should be superior in the case of polymer
scaffolds compared to the muscle.
It should be noted that due to low sensitivity of F-19
MRI, long acquisition times (1 h) were needed to visualize
the transplanted grafts in our study. Low spatial resolution
has been used to improve sensitivity, but it can also lead to
the sizes of small grafts being underestimated due to the
spreading of the signal in the image voxel [33]. Low
detection sensitivity of in vivo F-19 MRI has been also
reported in other models, e.g., examination of carbohydrates
sensitive to beta cells through GLUT-2 transporters in order
to visualize transplanted islets [40] and tracking transplanted
stem cells in the brain [33]. However, the ability to quantify
signals and estimate graft size without the use of radioactive
probes represents a considerable advantage.
Inhomogeneous B1 excitation when using the surface RF
coil is a further limitation. The F-19 MRI signal is
influenced not only by F-19 concentration, but also by the
distance from the coil. Other errors in quantification of the
F-19 MRI signal may arise from filtering during post-
processing, low measurement matrices, and Fourier trans-
form, potentially resulting in partial signal dispersion within
the whole measurement matrix [29, 41]. To overcome these
sensitivity problems and to improve F-19 SNR, various data
acquisition methods, such as compressed sensing [39] and
ultrashort echo sequences [42], have been proposed, which
could reduce imaging time while maintaining or even
improving the SNR. These advanced methods were not
available for our imaging system. Nevertheless, we have
shown here that the technique has sufficient sensitivity even
without optimal imaging sequences.
Although fluorescence imaging was found to be a more
sensitive method for cell tracking compared to F-19 MRI,
we observed a steep decline in the in vivo fluorescence
signal. Quenching of the fluorescence signal originating
from islets labeled by the high concentration of PLGA-NPs
has been described previously [29], but the fluorescence
signal used in this model decreased rapidly within 4 days
after transplantation. Fluorescence of labeled islets decreased
to a noise level within 1 week, while F-19 MRI and
bioluminescence signals decreased only partially. This
indicates the instability of the fluorescent dye (ICG) in the
nanoparticles under in vivo conditions. Thermal degradation
of ICG in other multifunctional perfluorocarbon
nanoemulsions at temperatures above 37 °C, which results
Fig. 6 Histology of scaffolds on day 14 after islet transplantation. Images of a transplanted graft with pancreatic islets stained
by hematoxylin/eosin (HE) and immunohistochemically with the primary antibodies anti-insulin and anti-luciferase. Insulin- and
luciferase-positive cells were present at the same locations within the graft. Scale bars correspond to 100 μm.
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in decreased light absorption and decreased fluorescence,
has been previously reported [43]. Alternatively, the dye
may leak out of the islets over time [17]. To confirm the
instability of the ICG dye in the nanoparticles, we performed
an in vitro experiment with long-term incubation of the
nanoparticles at various pH (5.8 and 7.4) and temperatures
(25 °C and 37 °C). We observed a decrease of the
fluorescence signal originating from the particles over time
(see Electronic Supplementary Material (ESM)). Moreover,
the strong fluorescence signal from the supernatant was
detected, which confirmed a substantial release of ICG from
the particles within the first 4 days (Fig. S1b ESM). The
release of ICG from the particles together with
photobleaching over time limits the reliability of longitudi-
nal in vivo fluorescence imaging with this probe.
The bioluminescence signal we observed correlated
strongly with the F-19 MRI signal from the transplanted
islets, which indicates that the probe was washed out after
cell death. This finding is in apparent contradiction to a
previously published study that used PFC-labeled neural
stem cells [33]. The authors of that study found that the
agent remained in the tissue, while the F-19 MRI signal
persisted even after cell death in the case of stem cells
transplanted into brain tissue. Another study, one that also
used lipid-coated emulsions, found that perfluoro-crown-
ether was retained at the site in a murine model of
inflammation for several months [44]. It should also be
noted that the F-19 labels used in these studies were different
(lipid-coated emulsion versus PLGA nanoparticles). More-
over, in the study of Liang et al., the results of BLI and F-19
MRI substantially differed suggesting a similar effect [25].
Different formulation may also significantly influence the
PFC clearance rate. Furthermore, the islets in our study were
transplanted into a well-vascularized site with good access to
circulating macrophages. We hypothesize that migrating
macrophages removed the nanoparticles together with the
remnants of the dead islets, thus eliminating their contribu-
tion to any false-positive results. In any case, clearance from
dead cells is essential for avoiding false-positives, a major
issue that we resolved through the use of PLGA-NPs.
Finally, histology revealed viable islet grafts in scaffolds
containing both labeled and unlabeled islets. It is significant
that insulin deposits were found at the same locations as
luciferase molecules, which confirmed the functionality of
transplanted LUC+ islets labeled with PLGA-NPs.
Conclusion
We present a novel platform for in vivo multimodal tracking
of transplanted pancreatic islets. Using three different
imaging methods, we obtained complementary information
on graft localization, size, and viability. The model
presented here may provide insights into the processes
connected with the engraftment and rejection of transplanted
pancreatic islets in a non-invasive and kinetic manner and be
of help to future in vivo studies. Although fluorescent
imaging of the ICG dye in PLGA-based nanoparticles was
also very sensitive shortly after transplantation, the instabil-
ity of the dye under longitudinal in vivo examination
represents substantial issues. Bioluminescence imaging
confirmed the viability of the transplanted islets throughout
the whole experiment. Importantly, the quantitative F-19
signal correlated strongly with islet viability, which indicates
that the PLGA-NPs are cleared from dead islets, thus
eliminating any false-positives from the F-19 MRI data.
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